A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

• Main Authors: R. Rupp (Author), D. Hurley (Author), S. Grayson (Author), J. Li (Author), K. Nolan (Author), R.D. McFetridge (Author), J. Hartzel (Author), C. Abeygunawardana (Author), M. Winters (Author), H. Pujar (Author), P. Benner (Author), L. Musey (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Two new formulations of an investigational 15-valent pneumococcal conjugate vaccine (PCV15-A and PCV15-B) were developed using 2 different protein-polysaccharide conjugation processes and evaluated in separate phase I/II studies (NCT02037984 [V114-004] and NCT02531373 [V114-005]) to asse...